Pure Global

錄秘帕斯 G 異常凝血酶原-N標準品組 - Taiwan Registration f9fac7911b60c9947fefb4d38d42e046

Access comprehensive regulatory information for 錄秘帕斯 G 異常凝血酶原-N標準品組 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f9fac7911b60c9947fefb4d38d42e046 and manufactured by Fujirebio Inc. Sagamihara Facility. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
f9fac7911b60c9947fefb4d38d42e046
Registration Details
Taiwan FDA Registration: f9fac7911b60c9947fefb4d38d42e046
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

錄秘帕斯 G 異常凝血酶原-N標準品組
Risk Class 2

Registration Details

f9fac7911b60c9947fefb4d38d42e046

DHA05603624008

Company Information

Product Details

專用於錄秘帕斯 G 異常凝血酶原-N 檢驗試劑 (Lumipulse PIVKA II-N) 之校正試劑組.

A Clinical chemistry and clinical toxicology

A.1150 Calibrated Products

QMS/QSD;; 輸入

Dates and Status

Dec 07, 2023

Dec 07, 2028